Xvivo Perfusion AB (XVIPF)
29.39
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Xvivo Perfusion Enterprise Value : 906.30M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Getinge AB | 5.889B |
| Paxman AB | 70.80M |
| Enovis Corp. | 2.759B |
| Edwards Lifesciences Corp. | 47.54B |
| IDEXX Laboratories, Inc. | 46.78B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.971M |
| Revenue (Quarterly) | 26.36M |
| Total Expenses (Quarterly) | 22.39M |
| EPS Diluted (Quarterly) | 0.1258 |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | 15.06% |
| Earnings Yield | 0.86% |
| Operating Earnings Yield | 1.07% |
| Normalized Earnings Yield | 0.853 |